CorMedix Inc. operates as a biopharmaceutical company. The company focuses on developing and commercializing therapeutic products for treatment life-threatening diseases and conditions.
The company’s primary focus has been commercializing DefenCath…
Analysis
Quality compounder
CorMedix Inc. is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is attractive. You pay 3.5× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.
The trajectory is moderate and the balance sheet is adequate. The company scores 20/20 on our value-creation score: strong value creator.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202557
82
20252026
All-time high
84
Mar 2026
All-time low
57
Jan 2025
Average rank
74
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
83
19
—
—
Price/Earnings
5
43
—
—
Price/Book
67
12
—
—
Dividend Yield
1
1
—
—
Value (overall)
86
8
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.